surgery News & Analysis

Medtronic (MDT) Gains FDA Approval for New Robotic Surgery Platform

Medtronic (MDT) received FDA approval for its Hugo robotic-assisted surgery platform in December 2025, allowing it to perform urologic procedures. The first successful use occurred at Cleveland Clinic shortly after. This market is projected to grow from $13.8 billion in 2022 to $63.7 billion by 2035, yet Medtronic faces significant competition from Intuitive Surgical, which dominates the market with over 11,395 da Vinci systems installed globally. With a recent application for broader procedure approvals, Medtronic aims to expand its market presence but may have an uphill battle against a well-entrenched competitor.